IPMK modulates hepatic glucose production and insulin signaling

Hepatic glucose production (HGP) is crucial for the maintenance of normal glucose homeostasis. Although hepatic insulin resistance contributes to excessive glucose production, its mechanism is not well understood. Here, we show that inositol polyphosphate multikinase (IPMK), a key enzyme in inositol polyphosphate biosynthesis, plays a role in regulating hepatic insulin signaling and gluconeogenesis both in vitro and in vivo. IPMK‐deficient hepatocytes exhibit decreased insulin‐induced activation of Akt‐FoxO1 signaling. The expression of messenger RNA levels of phosphoenolpyruvate carboxykinase 1 (Pck1) and glucose 6‐phosphatase (G6pc), key enzymes mediating gluconeogenesis, are increased in IPMK‐deficient hepatocytes compared to wild type hepatocytes. Importantly, re‐expressing IPMK restores insulin sensitivity and alleviates glucose production in IPMK‐deficient hepatocytes. Moreover, hepatocyte‐specific IPMK deletion exacerbates hyperglycemia and insulin sensitivity in mice fed a high‐fat diet, accompanied by an increase in HGP during pyruvate tolerance test and reduction in Akt phosphorylation in IPMK deficient liver. Our results demonstrate that IPMK mediates insulin signaling and gluconeogenesis and may be potentially targeted for treatment of diabetes.

[1]  S. Snyder,et al.  Loss of PI3k activity of inositol polyphosphate multikinase impairs PDK1-mediated AKT activation, cell migration, and intestinal homeostasis , 2020, bioRxiv.

[2]  Seyun Kim,et al.  Inositol polyphosphate multikinase in adipocytes is dispensable for regulating energy metabolism and whole-body metabolic homeostasis. , 2020, American journal of physiology. Endocrinology and metabolism.

[3]  Yup Kang,et al.  Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice , 2019, Scientific Reports.

[4]  P. Hamet,et al.  Environmental and genetic contributions to diabetes. , 2019, Metabolism: clinical and experimental.

[5]  F. White,et al.  High‐fat diet in a mouse insulin‐resistant model induces widespread rewiring of the phosphotyrosine signaling network , 2019, Molecular systems biology.

[6]  S. Snyder,et al.  IPMK Mediates Activation of ULK Signaling and Transcriptional Regulation of Autophagy Linked to Liver Inflammation and Regeneration , 2019, Cell reports.

[7]  P. Puigserver,et al.  Insulin regulation of gluconeogenesis , 2018, Annals of the New York Academy of Sciences.

[8]  G. Shulman,et al.  Regulation of hepatic glucose metabolism in health and disease , 2017, Nature Reviews Endocrinology.

[9]  M. Birnbaum,et al.  Unraveling the Regulation of Hepatic Metabolism by Insulin , 2017, Trends in Endocrinology & Metabolism.

[10]  C. Ballantyne,et al.  Skeletal muscle inflammation and insulin resistance in obesity , 2017, The Journal of clinical investigation.

[11]  Yup Kang,et al.  Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice , 2016, Scientific Reports.

[12]  Z. Ye,et al.  ULK1/2 Constitute a Bifurcate Node Controlling Glucose Metabolic Fluxes in Addition to Autophagy. , 2016, Molecular cell.

[13]  Eunha Kim,et al.  IPMK: A versatile regulator of nuclear signaling events. , 2016, Advances in biological regulation.

[14]  R. Ahima,et al.  The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. , 2016, Cell reports.

[15]  Mustafa Saad,et al.  Implications for Therapy , 2016 .

[16]  M. Birnbaum,et al.  Hepatic Insulin Signaling is Dispensable for Suppression of Glucose Output by Insulin in Vivo , 2015, Nature Communications.

[17]  I. Lucki,et al.  High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice , 2014, Neurobiology of Disease.

[18]  R. Ahima,et al.  Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action. , 2014, Molecular endocrinology.

[19]  S. Koo,et al.  CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis , 2013, BMB reports.

[20]  R. Tyagi,et al.  Inositol polyphosphate multikinase is a coactivator for serum response factor-dependent induction of immediate early genes , 2013, Proceedings of the National Academy of Sciences.

[21]  N. Sen,et al.  Inositol polyphosphate multikinase is a transcriptional coactivator required for immediate early gene induction , 2013, Proceedings of the National Academy of Sciences.

[22]  J. Florez,et al.  Gene-Environment and Gene-Treatment Interactions in Type 2 Diabetes , 2013, Diabetes Care.

[23]  F. Wondisford,et al.  Transcriptional Co-activator p300 Maintains Basal Hepatic Gluconeogenesis* , 2012, The Journal of Biological Chemistry.

[24]  E. Nagata,et al.  Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death , 2012, Proceedings of the National Academy of Sciences.

[25]  D. Hardie,et al.  AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.

[26]  C. Kahn,et al.  Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1 , 2012, Nature Medicine.

[27]  S. Snyder,et al.  AMP-activated protein kinase is physiologically regulated by inositol polyphosphate multikinase , 2011, Proceedings of the National Academy of Sciences.

[28]  D. Accili,et al.  Hormonal regulation of hepatic glucose production in health and disease. , 2011, Cell metabolism.

[29]  M. Montminy,et al.  CREB and the CRTC co-activators: sensors for hormonal and metabolic signals , 2011, Nature Reviews Molecular Cell Biology.

[30]  Michael A. Koldobskiy,et al.  Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase. , 2011, Cell metabolism.

[31]  S. Snyder,et al.  Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB , 2011, Proceedings of the National Academy of Sciences.

[32]  R. Rizza.  Pathogenesis of Fasting and Postprandial Hyperglycemia in Type 2 Diabetes: Implications for Therapy , 2010, Diabetes.

[33]  P. Roach,et al.  Molecular Characterization of Insulin-Mediated Suppression of Hepatic Glucose Production In Vivo , 2010, Diabetes.

[34]  R. DePinho,et al.  Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. , 2008, Cell metabolism.

[35]  R. DePinho,et al.  Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. , 2007, Cell metabolism.

[36]  J. Zierath,et al.  AMP-activated protein kinase signaling in metabolic regulation. , 2006, The Journal of clinical investigation.

[37]  M. Montminy,et al.  The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism , 2005, Nature.

[38]  S. Snyder,et al.  Inositol polyphosphate multikinase is a nuclear PI3-kinase with transcriptional regulatory activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Hogan,et al.  An essential role for an inositol polyphosphate multikinase, Ipk2, in mouse embryogenesis and second messenger production. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[41]  D. Breuillé,et al.  High-fat diet. , 2000 .

[42]  Y. Kido,et al.  Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue , 1998, Nature Genetics.